Clinical Trial Update: Using Differences in Peripheral Blood Leukocyte Gene Expression to Determine Cardiovascular Disease Risk

View source ↗

Summary

A completed clinical trial explored whether differences in peripheral blood leukocyte gene expression can predict cardiovascular disease risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Cardiovascular Diseases

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Atherosclerosis, Cardiovascular Diseases | Status: COMPLETED